(Q46810036)

25 December 2017

title

Comparison of weight gain in treatments for Tourette syndrome: tetrabenazine versus neuroleptic drugs (English)

1 reference

25 December 2017

1 reference

1 reference

William G Ondo

1

1 reference

25 December 2017

Daniel Jong

series ordinal

2

1 reference

25 December 2017

Anthony Davis

series ordinal

3

1 reference

25 December 2017

publication date

11 January 2008

1 reference

25 December 2017

Journal of Child Neurology

published in

1 reference

25 December 2017

volume

23

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

435-437

1 reference

25 December 2017

https://api.crossref.org/works/10.1177%2F0883073807307108

1 reference

A placebo-controlled trial of risperidone in Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073807307108

Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073807307108

Tetrabenazine in the treatment of hyperkinetic movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073807307108

Tetrabenazine treatment in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073807307108

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073807307108

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073807307108

21 January 2018

Identifiers

DOI

10.1177/0883073807307108

1 reference

25 December 2017

1 reference

25 December 2017